PFG Investments’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
Other funds holding ALT
DTC
TCM
RCM
PFG Investments's ALT Position: Q2 2026 in Review
PFG Investments increased its Altimmune (ALT) stake by 41% in Q2 2026, buying an estimated $16.4K and bringing the position to 19,000 shares worth $57.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1256.
PFG Investments first reported a position in ALT in Q2 2024 and has held it in 6 quarters since. The position peaked at $95.9K in Q4 2024. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.
- PFG Investments held 19,000 shares of Altimmune worth $57.8K as of Q2 2026.
- PFG Investments bought 5,500 Altimmune shares in Q2 2026, an estimated $16.4K.
- Altimmune made up ﹤0.01% of PFG Investments's portfolio in Q2 2026, its #1256 holding.
- PFG Investments first reported a position in Altimmune in Q2 2024 and has held it in 6 quarters since.
- PFG Investments's Altimmune position peaked at $95.9K in Q4 2024.
- 210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.
Based on PFG Investments's 13F filing for Q2 2026, filed 23 Jul 2026.